mithracin

Frequently asked questions

What does Mithracin treat?

Mithracin (Plicamycin) may be used to treat hypercalcemia, extramammary paget disease, testicular neoplasms, bcr-abl positive chronic myelogenous leukemia, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

How is Mithracin rated?

pharmaranks gives Mithracin a composite score of 3.2 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.

Is there a coupon or discount for Mithracin?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Mithracin. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Mithracin?

Mithracin is marketed by Pfizer. You can see Pfizer's full profile, rating, and other products on pharmaranks.

Is Mithracin a brand-name or generic drug?

Mithracin is a brand-name product with the active ingredient Plicamycin.

Is Mithracin available over the counter?

No. Mithracin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Mithracin come in?

Mithracin is currently marketed as injectable, per the FDA's National Drug Code Directory.

Is Mithracin FDA-registered?

Mithracin is on record with the U.S. FDA under application number NDA050109. You can verify this on its official FDA label.

Has Mithracin been recalled by the FDA?

Mithracin has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.

Is Mithracin safe?

There's no single safe-or-not verdict. pharmaranks gives Mithracin a recall-safety score of 64/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.